Alpha 2.0
Login Register
» Articles » PMID: 32170523

Homozygous IL1RN Mutation in Siblings with Deficiency of Interleukin-1 Receptor Antagonist (DIRA)

Overview
Journal J Clin Immunol
Publisher Springer
Specialty Allergy & Immunology
Date 2020 Mar 15
PMID 32170523
Citations 8
Authors
Vahid Ziaee
Leila Youssefian
Masoomeh Faghankhani
Ali Jazayeri
Amir Hossein Saeidian
Hassan Vahidnezhad
Jouni Uitto
Affiliations
Soon will be listed here.
Citing Articles

Deficiency of interleukin-1 receptor antagonist: A systematic review.

Goncalves Barros W, Goncalves Junior J Arch Rheumatol. 2025; 39(4):566-578.

PMID: 40060136 PMC: 11883257. DOI: 10.46497/ArchRheumatol.2024.10882.

Autoinflammatory Bone Diseases.

Haslak F, Akay N, Gul U, Gunalp A, Kilic Konte E, Sahin S Balkan Med J. 2025; 42(1):5-13.

PMID: 39757386 PMC: 11725671. DOI: 10.4274/balkanmedj.galenos.2024.2024-11-129.

Case report: Novel compound heterozygous mutations as the likely cause of a lethal form of deficiency of interleukin-1 receptor antagonist.

Urbaneja E, Bonet N, Solis-Moruno M, Mensa-Vilaro A, de Landazuri I, Tormo M Front Immunol. 2024; 15:1381447.

PMID: 38646532 PMC: 11026629. DOI: 10.3389/fimmu.2024.1381447.

IL-1RA autoantibodies: insights into mechanisms and associated diseases.

Bouayad A Am J Transl Res. 2024; 16(2):374-386.

PMID: 38463591 PMC: 10918145.

Analysis of Anakinra Therapy for the Deficiency of Interleukin-1 Receptor Antagonist through Clinical Evidence.

Pillai K, Pillai J, Ling J J Clin Med. 2024; 13(4).

PMID: 38398338 PMC: 10888712. DOI: 10.3390/jcm13041026.